These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17408502)

  • 1. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.
    Yetukuri L; Katajamaa M; Medina-Gomez G; Seppänen-Laakso T; Vidal-Puig A; Oresic M
    BMC Syst Biol; 2007 Feb; 1():12. PubMed ID: 17408502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-restricted feeding mice a high-fat diet induces a unique lipidomic profile.
    Mehus AA; Rust B; Idso JP; Hanson B; Zeng H; Yan L; Bukowski MR; Picklo MJ
    J Nutr Biochem; 2021 Feb; 88():108531. PubMed ID: 33098972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice.
    Hirako S; Wakayama Y; Kim H; Iizuka Y; Matsumoto A; Wada N; Kimura A; Okabe M; Sakagami J; Suzuki M; Takenoya F; Shioda S
    Obes Res Clin Pract; 2016; 10(6):710-718. PubMed ID: 26747210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes.
    Eisinger K; Krautbauer S; Hebel T; Schmitz G; Aslanidis C; Liebisch G; Buechler C
    Exp Mol Pathol; 2014 Aug; 97(1):37-43. PubMed ID: 24830603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse.
    González-Granillo M; Helguero LA; Alves E; Archer A; Savva C; Pedrelli M; Ahmed O; Li X; Domingues MR; Parini P; Gustafsson JÅ; Korach-André M
    Biol Sex Differ; 2019 Feb; 10(1):11. PubMed ID: 30808418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
    Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
    J Obes; 2013; 2013():296537. PubMed ID: 23401753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.
    Sarkar S; Kumari D; Gupta SK; Sharma V; Mukhi S; Kamboj P; Sasibhushan V; Rai RK; Jatavallabhula SL; Mahajan D; Kumar Y; Kumar A; Dikshit M
    Biomed Pharmacother; 2021 Dec; 144():112357. PubMed ID: 34794234
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lange M; Angelidou G; Ni Z; Criscuolo A; Schiller J; Blüher M; Fedorova M
    Cell Rep Med; 2021 Oct; 2(10):100407. PubMed ID: 34755127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls Promotes hepatic steatosis in male Ob/Ob mice.
    Mulligan C; Kondakala S; Yang EJ; Stokes JV; Stewart JA; Kaplan BL; Howell GE
    Environ Toxicol; 2017 Apr; 32(4):1399-1411. PubMed ID: 27533883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders.
    Johnson NA; Walton DW; Sachinwalla T; Thompson CH; Smith K; Ruell PA; Stannard SR; George J
    Hepatology; 2008 May; 47(5):1513-23. PubMed ID: 18393289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bile acid sequestration on hepatic steatosis in obese mice.
    Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational solutions in redox lipidomics - Current strategies and future perspectives.
    Ni Z; Goracci L; Cruciani G; Fedorova M
    Free Radic Biol Med; 2019 Nov; 144():110-123. PubMed ID: 31035005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can we learn from the platelet lipidome?
    Chicanne G; Darcourt J; Bertrand-Michel J; Garcia C; Ribes A; Payrastre B
    Platelets; 2023 Dec; 34(1):2182180. PubMed ID: 36880158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.
    Opazo-Ríos L; Soto-Catalán M; Lázaro I; Sala-Vila A; Jiménez-Castilla L; Orejudo M; Moreno JA; Egido J; Mas-Fontao S
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
    Nault R; Fader KA; Lydic TA; Zacharewski TR
    Chem Res Toxicol; 2017 Apr; 30(4):1060-1075. PubMed ID: 28238261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.